219 related articles for article (PubMed ID: 25799124)
21. From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents.
An DD; Kullgren B; Jarvis EE; Abergel RJ
Chem Biol Interact; 2017 Apr; 267():80-88. PubMed ID: 27038878
[TBL] [Abstract][Full Text] [Related]
22. Thorium(IV) complexes of bidentate hydroxypyridinonates.
Xu J; Whisenhunt DW; Veeck AC; Uhlir LC; Raymond KN
Inorg Chem; 2003 Apr; 42(8):2665-74. PubMed ID: 12691574
[TBL] [Abstract][Full Text] [Related]
23. (238)Pu elimination profiles after delayed treatment with 3,4,3LI(1,2HOPO) in female and male Swiss-Webster mice.
An DD; Villalobos JA; Morales-Rivera JA; Rosen CJ; Bjornstad KA; Gauny SS; Choi TA; Sturzbecher-Hoehne M; Abergel RJ
Int J Radiat Biol; 2014 Nov; 90(11):1055-61. PubMed ID: 24937372
[TBL] [Abstract][Full Text] [Related]
24. Comparative Study of a Decadentate Acyclic Chelate, HOPO-O
Carbo-Bague I; Li C; McNeil BL; Gao Y; McDonagh AW; Van de Voorde M; Ooms M; Kunz P; Yang H; Radchenko V; Schreckenbach G; Ramogida CF
Inorg Chem; 2023 Dec; 62(50):20549-20566. PubMed ID: 36608341
[TBL] [Abstract][Full Text] [Related]
25. Folding Dynamics of 3,4,3-LI(1,2-HOPO) in Its Free and Bound State with U
Wang Q; Liu Z; Song YF; Wang D
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500244
[TBL] [Abstract][Full Text] [Related]
26. Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89.
Pandya DN; Pailloux S; Tatum D; Magda D; Wadas TJ
Chem Commun (Camb); 2015 Feb; 51(12):2301-3. PubMed ID: 25556851
[TBL] [Abstract][Full Text] [Related]
27. Predicting the Thermodynamic Stability of Zirconium Radiotracers.
Holland JP
Inorg Chem; 2020 Feb; 59(3):2070-2082. PubMed ID: 31940188
[TBL] [Abstract][Full Text] [Related]
28. Octadentate hydroxypyridinonate (HOPO) ligands for plutonium (i.v.): pharmacokinetics and oral efficacy.
Durbin PW; Kullgren B; Xu J; Raymond KN; Hengé-Napoli MH; Bailly T; Burgada R
Radiat Prot Dosimetry; 2003; 105(1-4):503-8. PubMed ID: 14527018
[TBL] [Abstract][Full Text] [Related]
29. Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for
Seibold U; Wängler B; Wängler C
ChemMedChem; 2017 Sep; 12(18):1555-1571. PubMed ID: 28715615
[TBL] [Abstract][Full Text] [Related]
30. Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals.
Zhou X; Dong L; Shen L
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834087
[TBL] [Abstract][Full Text] [Related]
31. Sc-HOPO: A Potential Construct for Use in Radioscandium-Based Radiopharmaceuticals.
Phipps MD; Cingoranelli S; Bhupathiraju NVSDK; Younes A; Cao M; Sanders VA; Neary MC; Devany MH; Cutler CS; Lopez GE; Saini S; Parker CC; Fernandez SR; Lewis JS; Lapi SE; Francesconi LC; Deri MA
Inorg Chem; 2023 Dec; 62(50):20567-20581. PubMed ID: 36724083
[TBL] [Abstract][Full Text] [Related]
32. Aqueous complexation of thorium(IV), uranium(IV), neptunium(IV), plutonium(III/IV), and cerium(III/IV) with DTPA.
Brown MA; Paulenova A; Gelis AV
Inorg Chem; 2012 Jul; 51(14):7741-8. PubMed ID: 22738207
[TBL] [Abstract][Full Text] [Related]
33. Dose-dependent efficacy and safety toxicology of hydroxypyridinonate actinide decorporation agents in rodents: towards a safe and effective human dosing regimen.
Bunin DI; Chang PY; Doppalapudi RS; Riccio ES; An D; Jarvis EE; Kullgren B; Abergel RJ
Radiat Res; 2013 Feb; 179(2):171-82. PubMed ID: 23289385
[TBL] [Abstract][Full Text] [Related]
34. The solution thermodynamic stability of desferrioxamine B (DFO) with Zr(IV).
Toporivska Y; Gumienna-Kontecka E
J Inorg Biochem; 2019 Sep; 198():110753. PubMed ID: 31229836
[TBL] [Abstract][Full Text] [Related]
35. Biodistribution of the multidentate hydroxypyridinonate ligand [(14) C]-3,4,3-LI(1,2-HOPO), a potent actinide decorporation agent.
Choi TA; Endsley AN; Bunin DI; Colas C; An DD; Morales-Rivera JA; Villalobos JA; Shinn WM; Dabbs JE; Chang PY; Abergel RJ
Drug Dev Res; 2015 May; 76(3):107-22. PubMed ID: 25857483
[TBL] [Abstract][Full Text] [Related]
36. Optimization of the Sensitization Process and Stability of Octadentate Eu(III) 1,2-HOPO Complexes.
D'Aléo A; Moore EG; Xu J; Daumann LJ; Raymond KN
Inorg Chem; 2015 Jul; 54(14):6807-20. PubMed ID: 26151082
[TBL] [Abstract][Full Text] [Related]
37. Metal Coordination Properties of a Chromophoric Desferrioxamine (DFO) Derivative: Insight on the Coordination Stoichiometry and Thermodynamic Stability of Zr
Savastano M; Boscaro F; Bianchi A
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011419
[TBL] [Abstract][Full Text] [Related]
38. Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV).
Guérard F; Lee YS; Brechbiel MW
Chemistry; 2014 May; 20(19):5584-91. PubMed ID: 24740517
[TBL] [Abstract][Full Text] [Related]
39. Actinide chelation: biodistribution and in vivo complex stability of the targeted metal ions.
Kullgren B; Jarvis EE; An DD; Abergel RJ
Toxicol Mech Methods; 2013 Jan; 23(1):18-26. PubMed ID: 22957518
[TBL] [Abstract][Full Text] [Related]
40. In vitro metabolism and stability of the actinide chelating agent 3,4,3-LI(1,2-HOPO).
Choi TA; Furimsky AM; Swezey R; Bunin DI; Byrge P; Iyer LV; Chang PY; Abergel RJ
J Pharm Sci; 2015 May; 104(5):1832-8. PubMed ID: 25727482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
